A board-certified general surgeon and surgical oncologist, Kevin Roggin, MD, specializes in the surgical treatment of complex upper gastrointestinal tract and hepato-pancreato-biliary (HPB) cancers (stomach, pancreas, liver, gallbladder, gastrointestinal stromal tumors (GIST), sarcomas, extrahepatic bile duct cholangiocarcinoma). Dr. Roggin performs advanced robotic HPB procedures, including robotic pancreaticoduodenectomy (Whipple procedure), robotic distal pancreatectomy/splenectomy, robotic liver surgery and robotic gastric surgery.
Dr. Roggin serves as program director of the General Surgery Residency and associate program director of the Surgical Oncology Fellowship. He has held leadership positions in the Society of Surgical Oncology (SSO) as the chair of the Training Committee and is in his second three-year term on the SSO Executive Council.
Memorial Sloan-Kettering Cancer Center
NY
- Surgical Oncology
2005
University of Alabama at Birmingham Hospitals
AL
- General Surgery
2003
Brown University
RI
- Research Fellowship
2000
Georgetown University School of Medicine
DC
M.D. - Medicine
1996
University of Michigan, Ann Arbor
MI
B.A. - Political Science
1992
Endoscopic Ultrasound Predicts Risk of Occult Intra-Abdominal Metastases in Localized Gastric Cancer: A Validation Study.
Endoscopic Ultrasound Predicts Risk of Occult Intra-Abdominal Metastases in Localized Gastric Cancer: A Validation Study. Gastroenterology Res. 2023 Feb; 16(1):9-16.
PMID: 36895700
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels.
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels. Ann Surg Oncol. 2022 12; 29(Suppl 3):616-617.
PMID: 35930113
Surgical considerations and outcomes of minimally invasive approaches for gastric cancer resection.
Surgical considerations and outcomes of minimally invasive approaches for gastric cancer resection. Cancer. 2022 11 15; 128(22):3910-3918.
PMID: 36191278
Extraskeletal myxoid chondrosarcoma: Clinicopathological features and outcomes from the United States sarcoma collaborative database.
Extraskeletal myxoid chondrosarcoma: Clinicopathological features and outcomes from the United States sarcoma collaborative database. J Surg Oncol. 2022 Dec; 126(8):1533-1542.
PMID: 35962783
ASO Visual Abstract: Extremity Soft Tissue Sarcoma-A Multi-institutional Validation of Prognostic Nomograms.
ASO Visual Abstract: Extremity Soft Tissue Sarcoma-A Multi-institutional Validation of Prognostic Nomograms. Ann Surg Oncol. 2022 05; 29(5):3304-3305.
PMID: 35088171
Bile leak incidence, risk factors and associated outcomes in patients undergoing hepatectomy: a contemporary NSQIP propensity matched analysis.
Bile leak incidence, risk factors and associated outcomes in patients undergoing hepatectomy: a contemporary NSQIP propensity matched analysis. Surg Endosc. 2022 08; 36(8):5710-5723.
PMID: 35467144
Development of a Two-Week Dedicated Robotic Surgery Curriculum for General Surgery Residents.
Development of a Two-Week Dedicated Robotic Surgery Curriculum for General Surgery Residents. J Surg Educ. 2022 Jul-Aug; 79(4):861-866.
PMID: 35351431
Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.
Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms. Ann Surg Oncol. 2022 May; 29(5):3291-3301.
PMID: 35015183
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels.
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels. Ann Surg Oncol. 2022 Jan 05.
PMID: 34988836
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity.
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity. Am Surg. 2021 Nov; 87(11):1752-1759.
PMID: 34758653
SSO/SUS Scholarship for Leadership Agility Program
Society of Surgical Oncology
2019
Program Director of the Year
University of Chicago Medicine
2018 - 2019
Excellence in Teaching Award
University of Chicago Medicine
2017 - 2018
Excellence in Teaching Award
University of Chicago Medicine
2015 - 2016
Excellence in Teaching Award
University of Chicago Medicine
2014 - 2015
Distinguished Senior Educator Award
University of Chicago Biological Sciences Division
2014 - 2015
Senior Faculty Scholar
Bucksbaum Institute for Clinical Excellence, University of Chicago
2014
Excellence in Teaching Award
University of Chicago Medicine
2012 - 2013
Excellence in Teaching Award
University of Chicago Medicine
2011 - 2012
Best Poster, 17th Annual Huggins Research Conference
University of Chicago Medicine
2010
Fellow, Academy of Distinguished Medical Educators
University of Chicago Pritzker School of Medicine
2008 - 2019
Gold Humanism Honors Society
University of Chicago Pritzker School of Medicine
2008
Leonard Tow Humanism in Medicine Award
University of Chicago Pritzker School of Medicine
2008
Outstanding Faculty Member
University of Chicago Pritzker School of Medicine
2007 - 2008
Alpha Omega Alpha (faculty)
University of Chicago Pritzker School of Medicine
2007
Outstanding Faculty Member
University of Chicago Pritzker School of Medicine
2006 - 2007
Robert Baker Golden Apple Award
University of Chicago Medicine, Department of Surgery
2005 - 2006
Academic Achievement Award
University of Alabama at Birmingham Hospitals
2002 - 2003